化学试剂
NIBSC标准品 产品目录
发布时间:2017-12-08 17:33:27 产品编号:GY-5-178696671  分享
价格:0.00/参见厂家规格
品牌:NIBSC
发货:30天内
信息标签:NIBSC标准品 产品目录,供应,化工,化学试剂

点击这里进行电话呼叫
点击这里QQ咨询
联系时一定要说在【贸易商务资源网】看到的将给您优惠!如果您也想和该公司一样在网站发信息有好排名,点击立即免费注册,发布产品推广
 NIBSC标准品 产品目录    产品介绍:
        英国NIBSC是WHO的一个国际标准品供应中心实验室,它的核心工作是制备、保存和分发WHO用于检测全球生物制品质量的标准品。NIBSC制备的流感毒株和检测抗原、kang血清标准品,保障了各厂家顺利的研究和生产。NIBSC提供对投入英国市场的生物药品的独立测试,尤其是用于英国儿童免疫计划的疫苗;它同时也是欧盟控制药品进入欧盟市场的药品控制实验室。

 NIBSC标准品 产品目录    中国代理:
         深圳远扬生物技术有限公司专业代理英国NIBSC标准品,原厂订货,质量保证,并为您提供**的售后服务,欢迎OB来电详询。
         何经理    MOB:15012456311;   Q.Q: 277716420 ;   E-mail:  phastandards@gmail.com

 NIBSC标准品 产品目录    部分列表(随机排序):
(因篇幅有限,只列举部分产品列表,更多产品,欢迎来电)

13/273

Polio Anti Sabin type 56 (inactivated) Serum

95/594

Interleukin-55 (Human, rDNA derived)

95/602

Interleukin-63 (Human, rDNA derived)

95/633

Interleukin-94 (Human, rDNA derived)

01/504

Meningococcal serogroup W polysaccharide

10/115

Reteplase Reference Material

07/302

BCG Vaccine of Russian BCG-I sub-strain(29st WHO Reference Reagent)

10/145

Reteplase Reference Material

12/B623-028

QCRFLUAH1N1QC1-Influenza AH1N1 QC26

13/156

Influenza Antigen B/Massachusetts/02/2034 (Egg derived)

10/190

Reteplase Reference Material

03/104-113

HTLV-98 (antibody) Monitor Sample

95/614

Interleukin-75 (Human, rDNA derived)

03/104-105

HTLV-90 (antibody) Monitor Sample

13/221

Polio Anti Sabin type 4 (inactivated) Serum

03/104-082

HTLV-67 (antibody) Monitor Sample

13/284

Polio Anti Sabin type 67 (inactivated) Serum

13/290

Polio Anti Sabin type 73 (inactivated) Serum

95/565

Interleukin-26 (Human, rDNA derived)

13/234

C-Peptide, Human. 89st International Standard.

13/231

Polio Anti Sabin type 14 (inactivated) Serum

13/195

C-Peptide, Human. 50st International Standard.

13/211

Influenza Antigen B/Massachusetts/02/2089 (Egg derived)

12/B623-081

QCRFLUAH1N1QC1-Influenza AH1N1 QC79

03/104-095

HTLV-80 (antibody) Monitor Sample

95/644

Interleukin-105 (Human, rDNA derived)

13/237

C-Peptide, Human. 92st International Standard.

13/267

Polio Anti Sabin type 50 (inactivated) Serum

03/104-035

HTLV-20 (antibody) Monitor Sample

13/265

Polio Anti Sabin type 48 (inactivated) Serum

13/270

Polio Anti Sabin type 53 (inactivated) Serum

07/301

BCG Vaccine of Russian BCG-I sub-strain(28st WHO Reference Reagent)

13/243

C-Peptide, Human. 98st International Standard.

10/186

Reteplase Reference Material

13/285

Polio Anti Sabin type 68 (inactivated) Serum

03/104-017

HTLV-2 (antibody) Monitor Sample

13/167

Influenza Antigen B/Massachusetts/02/2045 (Egg derived)

03/104-052

HTLV-37 (antibody) Monitor Sample

13/251

C-Peptide, Human. 106st International Standard.

03/104-063

HTLV-48 (antibody) Monitor Sample

07/311

BCG Vaccine of Russian BCG-I sub-strain(38st WHO Reference Reagent)

95/617

Interleukin-78 (Human, rDNA derived)

01/442

Meningococcal serogroup W polysaccharide

01/506

Meningococcal serogroup W polysaccharide

07/362

BCG Vaccine of Russian BCG-I sub-strain(89st WHO Reference Reagent)

13/191

C-Peptide, Human. 46st International Standard.

03/104-106

HTLV-91 (antibody) Monitor Sample

13/149

C-Peptide, Human. 4st International Standard.

07/333

BCG Vaccine of Russian BCG-I sub-strain(60st WHO Reference Reagent)

13/258

Polio Anti Sabin type 41 (inactivated) Serum

07/365

BCG Vaccine of Russian BCG-I sub-strain(92st WHO Reference Reagent)

01/525

Meningococcal serogroup W polysaccharide

13/226

Influenza Antigen B/Massachusetts/02/2104 (Egg derived)

13/138

Influenza Antigen B/Massachusetts/02/2016 (Egg derived)

13/190

Influenza Antigen B/Massachusetts/02/2068 (Egg derived)

01/490

Meningococcal serogroup W polysaccharide

95/637

Interleukin-98 (Human, rDNA derived)

13/230

C-Peptide, Human. 85st International Standard.

01/533

Meningococcal serogroup W polysaccharide

12/B623-008

QCRFLUAH1N1QC1-Influenza AH1N1 QC6

13/219

Polio Anti Sabin type 2 (inactivated) Serum

95/651

Interleukin-112 (Human, rDNA derived)

10/211

Reteplase Reference Material

13/248

Polio Anti Sabin type 31 (inactivated) Serum

03/104-091

HTLV-76 (antibody) Monitor Sample

12/B623-062

QCRFLUAH1N1QC1-Influenza AH1N1 QC60

12/B623-025

QCRFLUAH1N1QC1-Influenza AH1N1 QC23

13/179

Influenza Antigen B/Massachusetts/02/2057 (Egg derived)

13/252

C-Peptide, Human. 107st International Standard.

07/298

BCG Vaccine of Russian BCG-I sub-strain(25st WHO Reference Reagent)

10/204

Reteplase Reference Material

03/104-048

HTLV-33 (antibody) Monitor Sample

10/203

Reteplase Reference Material

10/126

Reteplase Reference Material

03/104-034

HTLV-19 (antibody) Monitor Sample

01/464

Meningococcal serogroup W polysaccharide

95/590

Interleukin-51 (Human, rDNA derived)

13/240

C-Peptide, Human. 95st International Standard.

03/104-086

HTLV-71 (antibody) Monitor Sample

13/162

C-Peptide, Human. 17st International Standard.

12/B623-087

QCRFLUAH1N1QC1-Influenza AH1N1 QC85

13/237

Influenza Antigen B/Massachusetts/02/2115 (Egg derived)

10/114

Reteplase Reference Material

03/104-044

HTLV-29 (antibody) Monitor Sample

13/229

Polio Anti Sabin type 12 (inactivated) Serum

12/B623-031

QCRFLUAH1N1QC1-Influenza AH1N1 QC29

13/239

Influenza Antigen B/Massachusetts/02/2117 (Egg derived)

10/179

Reteplase Reference Material

95/649

Interleukin-110 (Human, rDNA derived)

13/163

Influenza Antigen B/Massachusetts/02/2041 (Egg derived)

03/104-068

HTLV-53 (antibody) Monitor Sample

13/177

Influenza Antigen B/Massachusetts/02/2055 (Egg derived)

13/224

Polio Anti Sabin type 7 (inactivated) Serum

13/216

C-Peptide, Human. 71st International Standard.

10/106

Reteplase Reference Material

01/514

Meningococcal serogroup W polysaccharide

95/564

Interleukin-25 (Human, rDNA derived)

13/232

Polio Anti Sabin type 15 (inactivated) Serum

10/119

Reteplase Reference Material

13/310

Polio Anti Sabin type 93 (inactivated) Serum

13/292

Polio Anti Sabin type 75 (inactivated) Serum

07/350

BCG Vaccine of Russian BCG-I sub-strain(77st WHO Reference Reagent)

01/500

Meningococcal serogroup W polysaccharide

13/134

Influenza Antigen B/Massachusetts/02/2012 (Egg derived)

13/235

C-Peptide, Human. 90st International Standard.

12/B623-071

QCRFLUAH1N1QC1-Influenza AH1N1 QC69

95/575

Interleukin-36 (Human, rDNA derived)

95/554

Interleukin-15 (Human, rDNA derived)

01/487

Meningococcal serogroup W polysaccharide

13/147

Influenza Antigen B/Massachusetts/02/2025 (Egg derived)

10/210

Reteplase Reference Material

10/168

Reteplase Reference Material

03/104-067

HTLV-52 (antibody) Monitor Sample

10/160

Reteplase Reference Material

07/352

BCG Vaccine of Russian BCG-I sub-strain(79st WHO Reference Reagent)

13/218

C-Peptide, Human. 73st International Standard.

12/B623-075

QCRFLUAH1N1QC1-Influenza AH1N1 QC73

01/479

Meningococcal serogroup W polysaccharide

13/165

Influenza Antigen B/Massachusetts/02/2043 (Egg derived)

13/194

Influenza Antigen B/Massachusetts/02/2072 (Egg derived)

13/156

C-Peptide, Human. 11st International Standard.

10/112

Reteplase Reference Material

13/184

Influenza Antigen B/Massachusetts/02/2062 (Egg derived)

03/104-057

HTLV-42 (antibody) Monitor Sample

03/104-075

HTLV-60 (antibody) Monitor Sample

01/511

Meningococcal serogroup W polysaccharide

13/220

Polio Anti Sabin type 3 (inactivated) Serum

03/104-045

HTLV-30 (antibody) Monitor Sample

01/478

Meningococcal serogroup W polysaccharide

10/104

Reteplase Reference Material

03/104-092

HTLV-77 (antibody) Monitor Sample

13/271

Polio Anti Sabin type 54 (inactivated) Serum

01/461

Meningococcal serogroup W polysaccharide

12/B623-005

QCRFLUAH1N1QC1-Influenza AH1N1 QC3

03/104-080

HTLV-65 (antibody) Monitor Sample

13/204

C-Peptide, Human. 59st International Standard.

13/319

Polio Anti Sabin type 102 (inactivated) Serum

13/173

C-Peptide, Human. 28st International Standard.

03/104-103

HTLV-88 (antibody) Monitor Sample

95/623

Interleukin-84 (Human, rDNA derived)

13/170

C-Peptide, Human. 25st International Standard.

13/255

Polio Anti Sabin type 38 (inactivated) Serum

01/472

Meningococcal serogroup W polysaccharide

07/335

BCG Vaccine of Russian BCG-I sub-strain(62st WHO Reference Reagent)

01/435

Meningococcal serogroup W polysaccharide

12/B623-039

QCRFLUAH1N1QC1-Influenza AH1N1 QC37

10/135

Reteplase Reference Material

95/630

Interleukin-91 (Human, rDNA derived)

07/374

BCG Vaccine of Russian BCG-I sub-strain(101st WHO Reference Reagent)

01/501

Meningococcal serogroup W polysaccharide

13/222

Influenza Antigen B/Massachusetts/02/2100 (Egg derived)

03/104-053

HTLV-38 (antibody) Monitor Sample

01/473

Meningococcal serogroup W polysaccharide

01/522

Meningococcal serogroup W polysaccharide

12/B623-090

QCRFLUAH1N1QC1-Influenza AH1N1 QC88

03/104-047

HTLV-32 (antibody) Monitor Sample

13/212

C-Peptide, Human. 67st International Standard.

12/B623-092

QCRFLUAH1N1QC1-Influenza AH1N1 QC90

13/143

Influenza Antigen B/Massachusetts/02/2021 (Egg derived)

12/B623-038

QCRFLUAH1N1QC1-Influenza AH1N1 QC36

10/174

Reteplase Reference Material

95/660

Interleukin-121 (Human, rDNA derived)

13/171

C-Peptide, Human. 26st International Standard.

03/104-109

HTLV-94 (antibody) Monitor Sample

03/104-054

HTLV-39 (antibody) Monitor Sample

13/257

Polio Anti Sabin type 40 (inactivated) Serum

10/170

Reteplase Reference Material

07/371

BCG Vaccine of Russian BCG-I sub-strain(98st WHO Reference Reagent)

01/498

Meningococcal serogroup W polysaccharide

95/658

Interleukin-119 (Human, rDNA derived)

07/297

BCG Vaccine of Russian BCG-I sub-strain(24st WHO Reference Reagent)

07/303

BCG Vaccine of Russian BCG-I sub-strain(30st WHO Reference Reagent)

01/431

Meningococcal serogroup W polysaccharide

07/366

BCG Vaccine of Russian BCG-I sub-strain(93st WHO Reference Reagent)

10/120

Reteplase Reference Material

13/239

Polio Anti Sabin type 22 (inactivated) Serum

13/259

Polio Anti Sabin type 42 (inactivated) Serum

13/208

Influenza Antigen B/Massachusetts/02/2086 (Egg derived)

03/104-101

HTLV-86 (antibody) Monitor Sample

13/281

Polio Anti Sabin type 64 (inactivated) Serum

95/616

Interleukin-77 (Human, rDNA derived)

12/B623-067

QCRFLUAH1N1QC1-Influenza AH1N1 QC65

13/235

Influenza Antigen B/Massachusetts/02/2113 (Egg derived)

13/148

C-Peptide, Human. 3st International Standard.

13/207

C-Peptide, Human. 62st International Standard.

13/254

Polio Anti Sabin type 37 (inactivated) Serum

03/104-062

HTLV-47 (antibody) Monitor Sample

13/225

Influenza Antigen B/Massachusetts/02/2103 (Egg derived)

07/336

BCG Vaccine of Russian BCG-I sub-strain(63st WHO Reference Reagent)

13/321

Polio Anti Sabin type 104 (inactivated) Serum

03/104-041

HTLV-26 (antibody) Monitor Sample

10/197

Reteplase Reference Material

95/592

Interleukin-53 (Human, rDNA derived)

13/169

C-Peptide, Human. 24st International Standard.

13/261

Polio Anti Sabin type 44 (inactivated) Serum

03/104-115

HTLV-100 (antibody) Monitor Sample

95/589

Interleukin-50 (Human, rDNA derived)

07/364

BCG Vaccine of Russian BCG-I sub-strain(91st WHO Reference Reagent)

13/153

Influenza Antigen B/Massachusetts/02/2031 (Egg derived)

03/104-084

HTLV-69 (antibody) Monitor Sample

10/146

Reteplase Reference Material

13/193

Influenza Antigen B/Massachusetts/02/2071 (Egg derived)

13/181

Influenza Antigen B/Massachusetts/02/2059 (Egg derived)

13/187

Influenza Antigen B/Massachusetts/02/2065 (Egg derived)

07/295

BCG Vaccine of Russian BCG-I sub-strain(22st WHO Reference Reagent)

13/227

Influenza Antigen B/Massachusetts/02/2105 (Egg derived)

07/314

BCG Vaccine of Russian BCG-I sub-strain(41st WHO Reference Reagent)

13/231

C-Peptide, Human. 86st International Standard.

13/238

Polio Anti Sabin type 21 (inactivated) Serum

95/560

Interleukin-21 (Human, rDNA derived)

13/226

Polio Anti Sabin type 9 (inactivated) Serum

95/566

Interleukin-27 (Human, rDNA derived)

13/185

C-Peptide, Human. 40st International Standard.

13/314

Polio Anti Sabin type 97 (inactivated) Serum

10/205

Reteplase Reference Material

13/212

Influenza Antigen B/Massachusetts/02/2090 (Egg derived)

07/367

BCG Vaccine of Russian BCG-I sub-strain(94st WHO Reference Reagent)

01/496

Meningococcal serogroup W polysaccharide

13/161

Influenza Antigen B/Massachusetts/02/2039 (Egg derived)

12/B623-056

QCRFLUAH1N1QC1-Influenza AH1N1 QC54

13/303

Polio Anti Sabin type 86 (inactivated) Serum

13/228

Influenza Antigen B/Massachusetts/02/2106 (Egg derived)

13/178

C-Peptide, Human. 33st International Standard.

01/470

Meningococcal serogroup W polysaccharide

10/195

Reteplase Reference Material

13/253

Polio Anti Sabin type 36 (inactivated) Serum

13/154

Influenza Antigen B/Massachusetts/02/2032 (Egg derived)

07/337

BCG Vaccine of Russian BCG-I sub-strain(64st WHO Reference Reagent)

03/104-046

HTLV-31 (antibody) Monitor Sample

13/236

Polio Anti Sabin type 19 (inactivated) Serum

12/B623-070

QCRFLUAH1N1QC1-Influenza AH1N1 QC68

01/509

Meningococcal serogroup W polysaccharide

13/171

Influenza Antigen B/Massachusetts/02/2049 (Egg derived)

13/142

Influenza Antigen B/Massachusetts/02/2020 (Egg derived)

07/368

BCG Vaccine of Russian BCG-I sub-strain(95st WHO Reference Reagent)

03/104-107

HTLV-92 (antibody) Monitor Sample

12/B623-011

QCRFLUAH1N1QC1-Influenza AH1N1 QC9

12/B623-029

QCRFLUAH1N1QC1-Influenza AH1N1 QC27

12/B623-052

QCRFLUAH1N1QC1-Influenza AH1N1 QC50

03/104-081

HTLV-66 (antibody) Monitor Sample

12/B623-093

QCRFLUAH1N1QC1-Influenza AH1N1 QC91

12/B623-078

QCRFLUAH1N1QC1-Influenza AH1N1 QC76

13/228

Polio Anti Sabin type 11 (inactivated) Serum

13/322

Polio Anti Sabin type 105 (inactivated) Serum

13/286

Polio Anti Sabin type 69 (inactivated) Serum

12/B623-043

QCRFLUAH1N1QC1-Influenza AH1N1 QC41

10/175

Reteplase Reference Material

07/319

BCG Vaccine of Russian BCG-I sub-strain(46st WHO Reference Reagent)

13/159

Influenza Antigen B/Massachusetts/02/2037 (Egg derived)

12/B623-050

QCRFLUAH1N1QC1-Influenza AH1N1 QC48

13/207

Influenza Antigen B/Massachusetts/02/2085 (Egg derived)

12/B623-073

QCRFLUAH1N1QC1-Influenza AH1N1 QC71

03/104-040

HTLV-25 (antibody) Monitor Sample

12/B623-082

QCRFLUAH1N1QC1-Influenza AH1N1 QC80

13/175

Influenza Antigen B/Massachusetts/02/2053 (Egg derived)

07/280

BCG Vaccine of Russian BCG-I sub-strain(7st WHO Reference Reagent)

10/150

Reteplase Reference Material

01/430

Meningococcal serogroup W polysaccharide

10/187

Reteplase Reference Material

13/151

Influenza Antigen B/Massachusetts/02/2029 (Egg derived)

13/256

Polio Anti Sabin type 39 (inactivated) Serum

10/194

Reteplase Reference Material

13/205

C-Peptide, Human. 60st International Standard.

12/B623-110

QCRFLUAH1N1QC1-Influenza AH1N1 QC108

01/528

Meningococcal serogroup W polysaccharide

13/162

Influenza Antigen B/Massachusetts/02/2040 (Egg derived)

13/203

C-Peptide, Human. 58st International Standard.

03/104-022

HTLV-7 (antibody) Monitor Sample

95/587

Interleukin-48 (Human, rDNA derived)

03/104-043

HTLV-28 (antibody) Monitor Sample

07/349

BCG Vaccine of Russian BCG-I sub-strain(76st WHO Reference Reagent)

95/562

Interleukin-23 (Human, rDNA derived)

95/607

Interleukin-68 (Human, rDNA derived)

12/B623-041

QCRFLUAH1N1QC1-Influenza AH1N1 QC39

07/315

BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent)

13/150

C-Peptide, Human. 5st International Standard.

01/458

Meningococcal serogroup W polysaccharide

07/283

BCG Vaccine of Russian BCG-I sub-strain(10st WHO Reference Reagent)

12/B623-083

QCRFLUAH1N1QC1-Influenza AH1N1 QC81

13/325

Polio Anti Sabin type 108 (inactivated) Serum

03/104-102

HTLV-87 (antibody) Monitor Sample

13/246

C-Peptide, Human. 101st International Standard.

10/132

Reteplase Reference Material

13/145

Influenza Antigen B/Massachusetts/02/2023 (Egg derived)

95/626

Interleukin-87 (Human, rDNA derived)

07/307

BCG Vaccine of Russian BCG-I sub-strain(34st WHO Reference Reagent)

12/B623-045

QCRFLUAH1N1QC1-Influenza AH1N1 QC43

95/593

Interleukin-54 (Human, rDNA derived)

13/237

Polio Anti Sabin type 20 (inactivated) Serum

07/309

BCG Vaccine of Russian BCG-I sub-strain(36st WHO Reference Reagent)

13/238

Influenza Antigen B/Massachusetts/02/2116 (Egg derived)

13/211

C-Peptide, Human. 66st International Standard.

01/447

Meningococcal serogroup W polysaccharide

07/282

BCG Vaccine of Russian BCG-I sub-strain(9st WHO Reference Reagent)

01/444

Meningococcal serogroup W polysaccharide

95/600

Interleukin-61 (Human, rDNA derived)

95/572

Interleukin-33 (Human, rDNA derived)

13/154

C-Peptide, Human. 9st International Standard.

07/322

BCG Vaccine of Russian BCG-I sub-strain(49st WHO Reference Reagent)

95/634

Interleukin-95 (Human, rDNA derived)



更多关于   NIBSC标准品 产品目录  的信息,欢迎联系 深圳远扬生物技术有限公司。
联系方式
公司:深圳远扬生物技术有限公司
状态:离线 发送信件
姓名:何德华(先生)
电话:0755-89554301
手机:15012456311
传真:0755-89554301
地区:广东-深圳市
地址:深圳市龙岗区龙平东路郭尾新村11号604室
QQ:781007885
商铺:http://m.ceoie.com/781007885/
去深圳远扬生物技术有限公司怎么走?上图中的红点是深圳远扬生物技术有限公司在深圳市的具体位置标注,操作左上角地图工具可以放大缩小哦。
相关信息
[化学试剂] 推荐供应
最新发布信息
点击分享到微信、朋友圈、QQ...
字母索引:  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

首页 | 公司 | 求购 | 供应 | 商城 | 招商 | 展会 | 行情 | 品牌 | 产品

联系我们 | 刷新 | 返回顶部

©2004-2024  贸易商务资源网(ceoie.com)  版权所有